List of Tables
Table 1. Global Cervical Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Cervical Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Cervical Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Cervical Cancer Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Cervical Cancer Molecular Diagnostics Market Share by Region (2019-2024)
Table 10. Global Cervical Cancer Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Cervical Cancer Molecular Diagnostics Market Share by Region (2025-2030)
Table 12. Cervical Cancer Molecular Diagnostics Market Trends
Table 13. Cervical Cancer Molecular Diagnostics Market Drivers
Table 14. Cervical Cancer Molecular Diagnostics Market Challenges
Table 15. Cervical Cancer Molecular Diagnostics Market Restraints
Table 16. Global Cervical Cancer Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Cervical Cancer Molecular Diagnostics Market Share by Players (2019-2024)
Table 18. Global Top Cervical Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cervical Cancer Molecular Diagnostics as of 2023)
Table 19. Ranking of Global Top Cervical Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Cervical Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cervical Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Cervical Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cervical Cancer Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Cervical Cancer Molecular Diagnostics Revenue Market Share by Type (2019-2024)
Table 27. Global Cervical Cancer Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Cervical Cancer Molecular Diagnostics Revenue Market Share by Type (2025-2030)
Table 29. Global Cervical Cancer Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Cervical Cancer Molecular Diagnostics Revenue Market Share by Application (2019-2024)
Table 31. Global Cervical Cancer Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Cervical Cancer Molecular Diagnostics Revenue Market Share by Application (2025-2030)
Table 33. North America Cervical Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Cervical Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Cervical Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Cervical Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Cervical Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Cervical Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Cervical Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Cervical Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cervical Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Hologic Company Detail
Table 49. Hologic Business Overview
Table 50. Hologic Cervical Cancer Molecular Diagnostics Product
Table 51. Hologic Revenue in Cervical Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 52. Hologic Recent Development
Table 53. Foundationmedicine Company Detail
Table 54. Foundationmedicine Business Overview
Table 55. Foundationmedicine Cervical Cancer Molecular Diagnostics Product
Table 56. Foundationmedicine Revenue in Cervical Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 57. Foundationmedicine Recent Development
Table 58. Roche Company Detail
Table 59. Roche Business Overview
Table 60. Roche Cervical Cancer Molecular Diagnostics Product
Table 61. Roche Revenue in Cervical Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 62. Roche Recent Development
Table 63. Hybribio Company Detail
Table 64. Hybribio Business Overview
Table 65. Hybribio Cervical Cancer Molecular Diagnostics Product
Table 66. Hybribio Revenue in Cervical Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 67. Hybribio Recent Development
Table 68. Daangene Company Detail
Table 69. Daangene Business Overview
Table 70. Daangene Cervical Cancer Molecular Diagnostics Product
Table 71. Daangene Revenue in Cervical Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 72. Daangene Recent Development
Table 73. Liferiver Company Detail
Table 74. Liferiver Business Overview
Table 75. Liferiver Cervical Cancer Molecular Diagnostics Product
Table 76. Liferiver Revenue in Cervical Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 77. Liferiver Recent Development
Table 78. KHB Company Detail
Table 79. KHB Business Overview
Table 80. KHB Cervical Cancer Molecular Diagnostics Product
Table 81. KHB Revenue in Cervical Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 82. KHB Recent Development
Table 83. Tellgen Company Detail
Table 84. Tellgen Business Overview
Table 85. Tellgen Cervical Cancer Molecular Diagnostics Product
Table 86. Tellgen Revenue in Cervical Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 87. Tellgen Recent Development
Table 88. YanengBIO Company Detail
Table 89. YanengBIO Business Overview
Table 90. YanengBIO Cervical Cancer Molecular Diagnostics Product
Table 91. YanengBIO Revenue in Cervical Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 92. YanengBIO Recent Development
Table 93. Gpmedical Company Detail
Table 94. Gpmedical Business Overview
Table 95. Gpmedical Cervical Cancer Molecular Diagnostics Product
Table 96. Gpmedical Revenue in Cervical Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 97. Gpmedical Recent Development
Table 98. Amoydx Company Detail
Table 99. Amoydx Business Overview
Table 100. Amoydx Cervical Cancer Molecular Diagnostics Product
Table 101. Amoydx Revenue in Cervical Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 102. Amoydx Recent Development
Table 103. Amplly Company Detail
Table 104. Amplly Business Overview
Table 105. Amplly Cervical Cancer Molecular Diagnostics Product
Table 106. Amplly Revenue in Cervical Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 107. Amplly Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cervical Cancer Molecular Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cervical Cancer Molecular Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. PCR Features
Figure 4. FISH Features
Figure 5. DNA Sequencing Features
Figure 6. Gene Chip Features
Figure 7. Global Cervical Cancer Molecular Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Cervical Cancer Molecular Diagnostics Market Share by Application: 2023 VS 2030
Figure 9. Clinical Diagnosis Case Studies
Figure 10. Drug Screening Case Studies
Figure 11. Research Case Studies
Figure 12. Cervical Cancer Molecular Diagnostics Report Years Considered
Figure 13. Global Cervical Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Cervical Cancer Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Cervical Cancer Molecular Diagnostics Market Share by Region: 2023 VS 2030
Figure 16. Global Cervical Cancer Molecular Diagnostics Market Share by Players in 2023
Figure 17. Global Top Cervical Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cervical Cancer Molecular Diagnostics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Cervical Cancer Molecular Diagnostics Revenue in 2023
Figure 19. North America Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Cervical Cancer Molecular Diagnostics Market Share by Country (2019-2030)
Figure 21. United States Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Cervical Cancer Molecular Diagnostics Market Share by Country (2019-2030)
Figure 25. Germany Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Share by Region (2019-2030)
Figure 33. China Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Cervical Cancer Molecular Diagnostics Market Share by Country (2019-2030)
Figure 41. Mexico Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Share by Country (2019-2030)
Figure 45. Turkey Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Hologic Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2019-2024)
Figure 48. Foundationmedicine Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2019-2024)
Figure 49. Roche Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2019-2024)
Figure 50. Hybribio Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2019-2024)
Figure 51. Daangene Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2019-2024)
Figure 52. Liferiver Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2019-2024)
Figure 53. KHB Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2019-2024)
Figure 54. Tellgen Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2019-2024)
Figure 55. YanengBIO Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2019-2024)
Figure 56. Gpmedical Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2019-2024)
Figure 57. Amoydx Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2019-2024)
Figure 58. Amplly Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed